Skip to content

Clinical trials

Breast Neoplasms trials in France with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Not applicable Country / region: France Clear all

317 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20044
20051
20066
20074
20088
20095
20105
201112
20127
201314
201413
201524
201623
201718
201817
201914
202020
202129
202223
202318
202419
202515
202614

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed155
Recruiting51
Unknown status35
Terminated35
Active, not recruiting26
Not yet recruiting8
Withdrawn6
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Institut du Cancer de Montpellier - Val d'Aurelle28
Centre Oscar Lambret16
Institut Cancerologie de l'Ouest16
Centre Georges Francois Leclerc13
Institut Curie13
Centre Francois Baclesse12
Institut Bergonié12
Hospices Civils de Lyon11
Institut Claudius Regaud11
UNICANCER11

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms317
Lung Neoplasms17
Prostatic Neoplasms14
Colorectal Neoplasms13
Neoplasms11
Ovarian Neoplasms9
Anxiety Disorders8
Colonic Neoplasms7
Fatigue7
Neoplasm Metastasis7

Trials

Showing 1 to 25 of 317. Each trial links to its page on Pharma Observatory.

217 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.